Fundraising Fox

Purespring

Founded 2020 · 58 employees on LinkedIn · 6 known investors

Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

Purespring was founded in 2020 by Moin Saleem.

MSMoin Saleem
Moin SaleeminCo-founder & Chief Scientific Advisor

Investors · 6

Sofinnova Partners✓ verifiedParis · $540K – $27M
Forbion✓ verifiedNaarden
Gilde Healthcare✓ verifiedUtrecht · $1.1M – $55M
SynconaLondon
British Patient Capitalreported · 2 sourcesLondon

Also in the syndicate · 1

Sofinnovalead

In the news

News - Purespring Therapeuticspurespringtx.com · Oct 2025Syncona's Purespring raises £80m in new financing - Sharecast.comsharecast.com · Oct 2024Purespring Therapeutics raises £80M to develop gene therapies aimed at kidney diseases — TFNtechfundingnews.com · Oct 2024Purespring Therapeutics Raises $105M in Series B Financingfinsmes.com · Oct 2024Purespring Therapeutics closed US$105,000,000 in a sensational growth funding round. | Startupmagstartupmag.co.uk · Oct 2024Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases - Purespring Therapeuticspurespringtx.com · Oct 2024

Frequently asked questions

What does Purespring do?
Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.
Who founded Purespring?
Purespring was founded by Moin Saleem in 2020.
Who are Purespring's investors?
Purespring's investors include Sofinnova Partners, Forbion, Gilde Healthcare, Syncona, British Patient Capital.